Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Amphastar Pharmaceuticals posted Q1 results last week that beat the bottom-line consensus. The stock appears cheap at under ...

While ILCG offers diversified growth exposure, its elevated volatility and lagging performance against top growth funds ...

Business leaders from major Hoosier companies say they are trying to navigate the uncertain trade environment created by ...

President Donald Trump's second term in office has been challenging for investors, at least so far. Trump imposed sweeping ...

Brigham Buhler, a MAHA influencer and biotech entrepreneur, has Robert F. Kennedy’s ear. But will RFK listen to his call to ...

The stock should perform well beyond 2030 thanks to its impressive innovative abilities. With a constellation of ...

Eli Lilly and Purdue University expand their partnership with a $250 million investment to advance pharmaceutical innovation ...

Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

Writer and director Rachel Feldman reflects on her heroine Lilly Ledbetter and all the mothers that helped bring her biopic to life ...

Eli Lilly and Company (NYSE: LLY) and Purdue University announced Friday (May 9) a significant expansion of their ...

Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a traditional defensive strategy.